Lifevantage (NASDAQ:LFVN) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Lifevantage (NASDAQ:LFVN) issued its earnings results on Thursday. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01), FiscalAI reports. Lifevantage had a return on equity of 23.89% and a net margin of 2.94%.

Lifevantage Price Performance

Shares of Lifevantage stock traded down $0.16 during trading on Thursday, hitting $6.45. 98,487 shares of the company’s stock traded hands, compared to its average volume of 272,342. The business has a 50-day simple moving average of $6.42 and a 200-day simple moving average of $5.83. The stock has a market capitalization of $81.40 million, a P/E ratio of 14.33 and a beta of 0.72. Lifevantage has a 1 year low of $3.90 and a 1 year high of $14.28.

Lifevantage Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.20 annualized dividend and a dividend yield of 3.1%. Lifevantage’s dividend payout ratio (DPR) is 44.44%.

Institutional Trading of Lifevantage

Large investors have recently modified their holdings of the company. Goldman Sachs Group Inc. grew its position in shares of Lifevantage by 305.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 200,222 shares of the company’s stock valued at $1,233,000 after acquiring an additional 150,785 shares during the period. Geode Capital Management LLC grew its position in shares of Lifevantage by 106.1% during the second quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock worth $3,210,000 after purchasing an additional 126,274 shares in the last quarter. Renaissance Technologies LLC grew its holdings in Lifevantage by 8.3% during the 4th quarter. Renaissance Technologies LLC now owns 922,918 shares of the company’s stock valued at $5,685,000 after buying an additional 70,900 shares in the last quarter. Advyzon Investment Management LLC grew its stake in Lifevantage by 346.3% during the fourth quarter. Advyzon Investment Management LLC now owns 62,277 shares of the company’s stock valued at $384,000 after acquiring an additional 48,322 shares in the last quarter. Finally, Walleye Capital LLC bought a new stake in shares of Lifevantage in the fourth quarter worth about $289,000. Institutional investors own 35.32% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on LFVN shares. Lake Street Capital downgraded Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 price target on the stock. in a report on Thursday, May 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of Lifevantage in a research note on Friday, August 21st. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $5.00.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.